NHS South of England Branded Medicines - Tranche A - September 2023
Estimated value
£249.8m
Awarded value
£249.8m
Suppliers
1
Lots
1
Published
14 Aug 2023
Description
NHS South of England Branded Medicines - Tranche A - September 2023 Offer reference number: CM/PHR/22/5676 CM/PHR/22/5676/01 - NHS Framework for South of England Branded Medicines - Tranche A. Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5676/02 - NHS Framework for South of England Branded Medicines - Annual Tranche. Period of framework: 1 September 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/22/5676/03 - NHS Framework Agreement for the supply of Risankizumab for the Midlands & East and North of England. Period of framework: 1 September 2023 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
Scope
- Reference
- CF-1622000D0O000000rwimUAA
- Total value
- £249,832,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 Aug 2023 to 30 Aug 2025
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 11 Apr 2023, 12:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£249.8m
Award date
17 Jul 2023
Contract start
31 Aug 2023
Contract end
30 Aug 2025